1-(bromomethyl)-1-fluorocyclopropane | 1314394-62-1

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机氟化物
• 英文名称: 1-(bromomethyl)-1-fluorocyclopropane
• CAS: 1314394-62-1
• 化学式: C₄H₆BrF
• 分子量: 152.994
• InChiKey: LQVPKSHJUGOHPN-UHFFFAOYSA-N

物化性质

• 沸点：
  117.6±13.0 °C(Predicted)
• 密度：
  1.61±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  6
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(bromomethyl)-1-fluorocyclopropane 在 肼 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 16.0h， 生成 ((1-fluorocyclopropyl)methyl)hydrazine
  参考文献：
  名称：

  [EN] PLASMA KALLIKREIN INHIBITORS
  [FR] INHIBITEURS DE KALLICRÉINE PLASMATIQUE

  摘要：

  本发明提供了式(I)的化合物及包含一种或多种所述化合物的制药组合物，以及使用所述化合物治疗或预防可能受益于抑制血浆卡利肌酶的一种或多种疾病状态的方法，包括遗传性血管性水肿、葡萄膜炎、后部葡萄膜炎、湿性年龄相关性黄斑水肿、糖尿病性黄斑水肿、糖尿病视网膜病变和视网膜静脉阻塞。这些化合物是血浆卡利肌酶的选择性抑制剂。

  公开号：

  WO2022109161A1
• 作为产物：
  描述：

  亚甲基环丙烷 在 N-溴代丁二酰亚胺(NBS) 、 triethylamine tris(hydrogen fluoride) 作用下， 以 二氯甲烷 为溶剂， 反应 5.0h， 生成 1-(bromomethyl)-1-fluorocyclopropane 、 1-fluoromethyl-1-bromocyclopropane
  参考文献：
  名称：

  A convenient approach towards the 1-aminomethyl-1-fluorocycloalkane scaffold

  摘要：

  A three-step synthesis towards 1-aminomethy1-1-fluorocycloalkanes was developed starting from methylenecycloalkanes. Methylenecyclobutane, methylenecyclopentane and methylenecyclohexane were first bromofluorinated to provide the corresponding Markovnikov products, 1-bromomethy1-1-fluorocycloalkanes, which were then converted towards the title compound via azide substitution and hydrogenation. The bromofluorination of methylenecyclopropane, however, led to both the Markovnikov and the anti-Markovnikov product. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2013.08.127

文献信息

• [EN] CD73 INHIBITING 2,4-DIOXOPYRIMIDINE COMPOUNDS<br/>[FR] COMPOSÉS DE 2,4-DIOXOPYRIMIDINE INHIBANT CD73
  申请人：GILEAD SCIENCES INC

  公开号：WO2021222522A1

  公开（公告）日：2021-11-04

  The present disclosure provides pyrimidine dione compounds, and pharmaceutical compositions thereof, for treating cancer, including solid tumors. The compounds can be used alone or in combination with other anti-cancer agents.

  本公开提供了嘧啶二酮类化合物及其药物组合物，用于治疗癌症，包括实体肿瘤。这些化合物可以单独使用或与其他抗癌药物联合使用。
• ACRYLIC ACID DERIVATIVE, PREPARATION METHOD AND USE IN MEDICINE THEREOF
  申请人：Zhejiang Hisun Pharmaceutical Co., Ltd.

  公开号：EP3378861B1

  公开（公告）日：2021-08-04
• A convenient approach towards the 1-aminomethyl-1-fluorocycloalkane scaffold
  作者：Matthias Moens、Matthias D’hooghe、Norbert De Kimpe

  DOI：10.1016/j.tetlet.2013.08.127

  日期：2013.11

  A three-step synthesis towards 1-aminomethy1-1-fluorocycloalkanes was developed starting from methylenecycloalkanes. Methylenecyclobutane, methylenecyclopentane and methylenecyclohexane were first bromofluorinated to provide the corresponding Markovnikov products, 1-bromomethy1-1-fluorocycloalkanes, which were then converted towards the title compound via azide substitution and hydrogenation. The bromofluorination of methylenecyclopropane, however, led to both the Markovnikov and the anti-Markovnikov product. (C) 2013 Elsevier Ltd. All rights reserved.
• [EN] PLASMA KALLIKREIN INHIBITORS<br/>[FR] INHIBITEURS DE KALLICRÉINE PLASMATIQUE
  申请人：MERCK SHARP & DOHME

  公开号：WO2022109161A1

  公开（公告）日：2022-05-27

  The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.

  本发明提供了式(I)的化合物及包含一种或多种所述化合物的制药组合物，以及使用所述化合物治疗或预防可能受益于抑制血浆卡利肌酶的一种或多种疾病状态的方法，包括遗传性血管性水肿、葡萄膜炎、后部葡萄膜炎、湿性年龄相关性黄斑水肿、糖尿病性黄斑水肿、糖尿病视网膜病变和视网膜静脉阻塞。这些化合物是血浆卡利肌酶的选择性抑制剂。